Brandywine Global Investment Management LLC grew its holdings in shares of Perrigo Company plc (NYSE:PRGO) by 45.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 121,237 shares of the company’s stock after purchasing an additional 37,727 shares during the quarter. Brandywine Global Investment Management LLC owned approximately 0.09% of Perrigo worth $10,568,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in PRGO. Crossmark Global Holdings Inc. acquired a new stake in Perrigo during the 3rd quarter worth $605,000. Canada Pension Plan Investment Board boosted its stake in Perrigo by 163.7% during the 3rd quarter. Canada Pension Plan Investment Board now owns 66,748 shares of the company’s stock worth $5,630,000 after purchasing an additional 41,438 shares during the last quarter. Andra AP fonden boosted its stake in Perrigo by 9.9% during the 3rd quarter. Andra AP fonden now owns 16,700 shares of the company’s stock worth $1,414,000 after purchasing an additional 1,500 shares during the last quarter. Chicago Equity Partners LLC acquired a new stake in Perrigo during the 3rd quarter worth $313,000. Finally, Swiss National Bank boosted its stake in Perrigo by 1.1% during the 3rd quarter. Swiss National Bank now owns 475,462 shares of the company’s stock worth $40,248,000 after purchasing an additional 5,400 shares during the last quarter. 79.01% of the stock is currently owned by institutional investors.
Several brokerages have issued reports on PRGO. Canaccord Genuity set a $105.00 target price on shares of Perrigo and gave the stock a “buy” rating in a research note on Monday. Oppenheimer set a $98.00 price target on Perrigo and gave the stock a “buy” rating in a report on Monday, March 5th. Cantor Fitzgerald set a $107.00 price target on Perrigo and gave the stock a “buy” rating in a report on Thursday, March 1st. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and set a $83.00 price target (up previously from $82.00) on shares of Perrigo in a report on Monday, March 5th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and nine have given a buy rating to the company’s stock. Perrigo presently has a consensus rating of “Hold” and a consensus target price of $91.88.
Shares of Perrigo Company plc (NYSE:PRGO) opened at $86.51 on Wednesday. The stock has a market cap of $12,130.00, a PE ratio of 102.99, a P/E/G ratio of 1.96 and a beta of 0.73. Perrigo Company plc has a fifty-two week low of $63.68 and a fifty-two week high of $95.93. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.96 and a quick ratio of 1.40.
Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Thursday, March 1st. The company reported $1.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.25 by $0.03. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.26 billion. Perrigo had a net margin of 2.42% and a return on equity of 11.54%. Perrigo’s revenue was down 3.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.24 EPS. equities analysts predict that Perrigo Company plc will post 5.25 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 2nd will be issued a $0.19 dividend. This is a positive change from Perrigo’s previous quarterly dividend of $0.16. This represents a $0.76 annualized dividend and a yield of 0.88%. The ex-dividend date is Thursday, March 1st. Perrigo’s payout ratio is 90.48%.
ILLEGAL ACTIVITY NOTICE: This report was first published by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/03/14/brandywine-global-investment-management-llc-acquires-37727-shares-of-perrigo-company-plc-prgo.html.
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.